4DMedical Limited
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function im… Read more
Market Cap & Net Worth: 4DMedical Limited (FDMDF)
4DMedical Limited (PINK:FDMDF) has a market capitalization of $193.87 Million ($193.87 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #16844 globally and #6451 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 4DMedical Limited's stock price $0.34 by its total outstanding shares 570191242 (570.19 Million).
4DMedical Limited Market Cap History: 2021 to 2025
4DMedical Limited's market capitalization history from 2021 to 2025. Data shows change from $746.95 Million to $193.87 Million (-31.43% CAGR).
4DMedical Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 4DMedical Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
33.12x
4DMedical Limited's market cap is 33.12 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $746.95 Million | $216.98K | -$21.42 Million | 3442.52x | N/A |
| 2022 | $126.58 Million | $1.05 Million | -$24.59 Million | 120.06x | N/A |
| 2023 | $310.13 Million | $718.58K | -$31.46 Million | 431.58x | N/A |
| 2024 | $193.87 Million | $3.05 Million | -$35.98 Million | 63.57x | N/A |
| 2025 | $193.87 Million | $5.85 Million | -$30.07 Million | 33.12x | N/A |
Competitor Companies of FDMDF by Market Capitalization
Companies near 4DMedical Limited in the global market cap rankings as of March 18, 2026.
Key companies related to 4DMedical Limited by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
4DMedical Limited Historical Marketcap From 2021 to 2025
Between 2021 and today, 4DMedical Limited's market cap moved from $746.95 Million to $ 193.87 Million, with a yearly change of -31.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $193.87 Million | 0.00% |
| 2024 | $193.87 Million | -37.49% |
| 2023 | $310.13 Million | +145.00% |
| 2022 | $126.58 Million | -83.05% |
| 2021 | $746.95 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of 4DMedical Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $193.87 Million USD |
| MoneyControl | $193.87 Million USD |
| MarketWatch | $193.87 Million USD |
| marketcap.company | $193.87 Million USD |
| Reuters | $193.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.